tradingkey.logo
tradingkey.logo

AtriCure Inc

ATRC
40.330USD
-0.220-0.54%
終値 12/26, 16:00ET15分遅れの株価
2.00B時価総額
損失額直近12ヶ月PER

AtriCure Inc

40.330
-0.220-0.54%

詳細情報 AtriCure Inc 企業名

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Incの企業情報

企業コードATRC
会社名AtriCure Inc
上場日Aug 05, 2005
最高経営責任者「CEO」Carrel (Michael H)
従業員数1300
証券種類Ordinary Share
決算期末Aug 05
本社所在地7555 Innovation Way
都市MASON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号45040
電話番号15137554100
ウェブサイトhttps://www.atricure.com
企業コードATRC
上場日Aug 05, 2005
最高経営責任者「CEO」Carrel (Michael H)

AtriCure Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
702.94K
-0.85%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
78.80K
-6.15%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-6.78%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+32.18%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+41.20%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
702.94K
-0.85%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
78.80K
-6.15%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
110.58M
81.23%
Europe
16.13M
11.85%
Asia
7.48M
5.50%
Other international
1.94M
1.42%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.71%
Wellington Management Company, LLP
8.63%
AllianceBernstein L.P.
7.16%
BlackRock Institutional Trust Company, N.A.
6.86%
Hood River Capital Management LLC
6.13%
他の
61.50%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.71%
Wellington Management Company, LLP
8.63%
AllianceBernstein L.P.
7.16%
BlackRock Institutional Trust Company, N.A.
6.86%
Hood River Capital Management LLC
6.13%
他の
61.50%
種類
株主統計
比率
Investment Advisor
51.23%
Investment Advisor/Hedge Fund
39.51%
Hedge Fund
5.89%
Individual Investor
3.47%
Research Firm
1.65%
Pension Fund
0.79%
Bank and Trust
0.54%
Family Office
0.07%
Insurance Company
0.03%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
492
49.59M
116.79%
-102.71K
2025Q3
520
49.71M
119.25%
-705.98K
2025Q2
524
50.25M
121.23%
-1.55M
2025Q1
527
51.69M
113.33%
-4.41M
2024Q4
514
47.94M
122.38%
-3.05M
2024Q3
505
52.36M
125.18%
-207.95K
2024Q2
494
52.59M
116.92%
+1.07M
2024Q1
500
51.55M
109.93%
-1.63M
2023Q4
498
48.92M
106.78%
+1.54M
2023Q3
486
47.46M
108.31%
+99.25K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
4.90M
9.85%
+191.85K
+4.08%
Jun 30, 2025
Wellington Management Company, LLP
3.97M
7.99%
+3.27M
+465.38%
Jun 30, 2025
AllianceBernstein L.P.
3.57M
7.19%
-103.20K
-2.81%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.45M
6.94%
-124.60K
-3.49%
Jun 30, 2025
Hood River Capital Management LLC
3.06M
6.16%
+61.85K
+2.06%
Jun 30, 2025
Nomura Investment Management Business Trust
2.50M
5.04%
+66.37K
+2.72%
Jun 30, 2025
Champlain Investment Partners, LLC
2.02M
4.06%
-121.21K
-5.67%
Jun 30, 2025
State Street Investment Management (US)
1.27M
2.56%
-4.56K
-0.36%
Jun 30, 2025
Neuberger Berman, LLC
1.19M
2.39%
+3.67K
+0.31%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.18M
2.38%
+14.58K
+1.25%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
1.75%
Harbor Human Capital Factor US Small Cap ETF
0.7%
Invesco NASDAQ Future Gen 200 ETF
0.5%
First Trust Small Cap Growth AlphaDEX Fund
0.44%
Fidelity Enhanced Small Cap ETF
0.33%
Amplify Etho Climate Leadership U.S. ETF
0.3%
Franklin US Small Cap Multifactor Index ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.24%
iShares U.S. Medical Devices ETF
0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.17%
詳細を見る
State Street SPDR S&P Health Care Equipment ETF
比率1.75%
Harbor Human Capital Factor US Small Cap ETF
比率0.7%
Invesco NASDAQ Future Gen 200 ETF
比率0.5%
First Trust Small Cap Growth AlphaDEX Fund
比率0.44%
Fidelity Enhanced Small Cap ETF
比率0.33%
Amplify Etho Climate Leadership U.S. ETF
比率0.3%
Franklin US Small Cap Multifactor Index ETF
比率0.25%
JPMorgan Fundamental Data Science Small Core ETF
比率0.24%
iShares U.S. Medical Devices ETF
比率0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.17%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

AtriCure Incの上位5名の株主は誰ですか?

AtriCure Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は4.90M株を保有しており、これは全体の9.85%に相当します。
Wellington Management Company, LLPは3.97M株を保有しており、これは全体の7.99%に相当します。
AllianceBernstein L.P.は3.57M株を保有しており、これは全体の7.19%に相当します。
BlackRock Institutional Trust Company, N.A.は3.45M株を保有しており、これは全体の6.94%に相当します。
Hood River Capital Management LLCは3.06M株を保有しており、これは全体の6.16%に相当します。

AtriCure Incの株主タイプ上位3種は何ですか?

AtriCure Incの株主タイプ上位3種は、
The Vanguard Group, Inc.
Wellington Management Company, LLP
AllianceBernstein L.P.

AtriCure Inc(ATRC)の株式を保有している機関の数はいくつですか?

2025Q4時点で、AtriCure Incの株式を保有している機関は492社あり、保有株式の総市場価値は約49.59Mで、全体の116.79%を占めています。2025Q3と比較して、機関の持ち株は-2.47%増加しています。

AtriCure Incの最大の収益源は何ですか?

FY2025Q2において、--部門がAtriCure Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI